2026-10-23 04:40:27 UTC#504177newconfirmednews
MEDS stock news
MEDS stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire16 wire items
2026-10-22 12:32:03 UTC#499961duplicateconfirmednews
Datavault AI signs non-binding LOI to acquire 19.9% stake in DataMEDS AI
2026-10-22 12:13:49 UTC#499859updateconfirmednews
Datavault AI signs letter of intent to acquire 19.9% stake in DataMEDS AI
2026-10-22 12:05:00 UTC#499824newconfirmednews
Datavault AI to appoint one director to DataMEDS board upon closing of proposed transaction
2026-10-20 10:00:00 UTC#485613newconfirmednews
DataMeds AI (MEDS) regains Nasdaq listing compliance after meeting $2.5M stockholders' equity requirement
2026-10-16 21:22:36 UTC#474229newconfirmednews
DataMeds AI (MEDS) secures exclusive US IP license from Reboot Health AI for stock and cash consideration
2026-10-01 10:00:00 UTC#397493newconfirmednews
DataMeds AI (MEDS) reports Corexa Pharmacy September revenue exceeded $1M, up 66% from July
tradingviewimportance 0.40trust 0.60DataMeds AI, Inc. +0.50Corexa Pharmacy +0.50Tollo Health +0.40+1 entities
2026-09-15 12:32:00 UTC#313669newconfirmednews
Axe Compute divests Helomics to DataMEDS in exchange for common shares and equivalents
2026-09-15 12:31:00 UTC#313671duplicateconfirmednews
Axe Compute divests Helomics cancer diagnostics business to DataMEDS AI
2026-09-15 12:30:00 UTC#313694duplicateconfirmednews
Axe Compute completes sale of Helomics to DataMEDS for stock, shifts to pure-play GPUaaS
2026-08-17 10:11:01 UTC#183855newconfirmeddata release
DataMeds AI, Inc. Q2 2026 Revenue $1.78M vs $7.79M YoY; Net Loss Widens to $18.36M
2026-07-21 08:10:44 UTC#56130duplicateconfirmednews
Meds Apotek reports record Q2 revenue of SEK 304M, up 18% YoY, with EBIT growth of 38%
2026-07-21 05:39:26 UTC#55646newconfirmednews
Meds Apotek Q2 revenue rises 18% to SEK 304M, adjusted EPS turns positive to SEK 0.31
2026-07-21 05:34:00 UTC#55609duplicateconfirmednews
MedCap Q2 2026 net sales rise 17.6% with strong RX segment growth
2026-07-21 05:01:56 UTC#55513duplicateconfirmednews
MedCap Q2 2026 reports 16% revenue growth and 28% EBITA growth driven by M&A and organic gains
2026-07-21 04:40:31 UTC#55424duplicateconfirmednews